Can serum endoglin be used to improve the diagnostic performance in prostate cancer?
Can serum endoglin be used to improve the diagnostic performance in prostate cancer?
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
New biomarkers may contribute to avoid unnecessary biopsies resulting from the suboptimal performance of prostate-specific antigen (PSA) testing. This study aimed to assess serum endoglin as a prostate cancer (PCa) diagnostic tool among biopsy candidates.
Methods
A total of 262 consecutive patients referred for prostate biopsy base...
Alternative Titles
Full title
Can serum endoglin be used to improve the diagnostic performance in prostate cancer?
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2528906698
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2528906698
Other Identifiers
ISSN
0724-4983
E-ISSN
1433-8726
DOI
10.1007/s00345-021-03714-5
